Cerevance Beta
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, Cerevance Beta sits in the upper quartile of US sponsors by registered trial count (#2,913 of 15,742 sponsors by registered trial count).
Cerevance Beta: 4 sponsored US clinical trials, none currently recruiting.
Cerevance Beta sponsors 4 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 4 completed. 0 of these trials are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Parkinson's Disease, with 2 trials.
Upper-quartile sponsor footprint
Cerevance Beta sits in the upper quartile of the sponsor corpus (#2,913 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
4 total, page 1 of 1
Early Parkinson's Disease Monotherapy With CVN424
NCT06006247
Relative Bioavailability and Food Effect Study of CVN424
NCT05635461
Study of CVN424 in Parkinson's Disease Patients With Motor Fluctuations
NCT04191577
Study of CVN424 in Healthy Subjects
NCT03657030
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 2 |
Therapeutic Areas
How the Cerevance Beta early-phase archive is shaped
4 indexed studies, none listed as recruiting (0% open); 4 completed (100%).
Phase mix: 0 late (III/IV) vs 4 early (I/II) (early-phase heavy).
Top condition: Parkinson's Disease (2 trials), 0 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Cerevance Beta: archived-pipeline peers nationwide
Peers matched on 4 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Cerevance Beta sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 4 archived trials
- 4D pharma · 4 trials · 0% recruiting
- 60 Degrees Pharmaceuticals · 4 trials · 50% recruiting
- A2 Biotherapeutics · 4 trials · 75% recruiting
- Abdul Latif Jameel Poverty Action Lab · 4 trials · 25% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Cerevance Beta page
4 registered trials is a research-attention snapshot, not an endorsement of Cerevance Beta or any single study.
- None of Cerevance Beta's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Parkinson's Disease is the condition Cerevance Beta studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Parkinson's Disease trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Cerevance Beta pipeline card: 4 registered trials from official public datasets.Report a data error.